Pharmaceutical Tablets

Product Price :Get Latest Price

KOLDOVIN
Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets

COMPOSITION:
Each uncoated tablets contains:
Paracetamol BP................ 500mg
Phenylephrine Hydrochloride BP.....10mg
Chlorpheniramine Maleate BP......... 2mg
Excipients ...................... q.s

INDICATION:

Symptomatic relief of common cold, congestion associated with sinusitis, allergic rhinitis accompanied by fever and pain.

Specification:
Symptomatic relief of common cold, congestion associated with sinusitis, allergic rhinitis accompanied by fever and pain

Additional Information:

• Item Code: T029
• Packaging Details: 2 x 10 Tablets in printed carton with pack insert.

Product Price :Get Latest Price

Each film coated tablet contains:
Carvedilol USP ............. 12.5 mg
Excipients ........................... q.s.
Colour : Sunset Yellow

a)         Essential hypertension

b)        Chronic stable angina pectoris

c)         Adjunctive treatment of moderate to severe stable chronic
            heart failure

Additional Information:

• Packaging Details: 10 x 10 tablets in printed carton with pack insert.

Product Price :Get Latest Price

Specification :     Used in ;

- uncomplicated P.falciparum malaria including multi-drug resistant strains of P.falciparum

- malaria infections acquired in areas where the parasites may be resistant to other anti-malarial drugs

Additional Information:

• Packaging Details: 10 x 1 x 10 Tablets in printed carton with pack insert.

Product Price :Get Latest Price

Specification : For temporary relief of pain associated with: headache, migraine, backache, period pain, dental pain, muscular pain, cold and flu symptoms, sore throat and fever.

Additional Information:

• Packaging Details: 100 ml Bottle In printed carton with pack insert.

Product Price :Get Latest Price

Each Film coated Tablet Contains:
Risperidone USP   2mg
Excipients               q.s.

INDICATION:
Risperidone tablets is indicated for the treatment of schizophrenia.
Risperidone tablets is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorders.
Risperidone tablets is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.
Risperidone tablets is indicated for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with sub average intellectual functioning or mental retardation diagnosed according to DSM-IV criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment. It is recommended that risperidone be prescribed by a specialist in child neurology and child and adolescent psychiatry or physicians well familiar with the treatment of conduct disorder of children and adolescents.

DOSAGE AND ADMINISTRATION:
Schizophrenia
Adults
Risperidone tablets may be given once daily or twice daily.
Patients should start with 2 mg/day risperidone. The dosage may be increased on the second day to 4 mg.
Manic episodes in bipolar disorder
Adults
Risperidone tablets should be administered on a once daily schedule, starting with 2 mg risperidone. Dosage adjustments, if indicated, should occur at intervals of not less than 24 hours and in dosage increments of 1 mg per day.
Schizophrenia & Manic episodes in bipolar disorder
Elderly : A starting dose of 0.5 mg twice daily is recommended. This dosage can be individually adjusted with 0.5 mg twice daily increments to 1 to 2 mg twice daily.
Paediatric population
Risperidone is not recommended for use in children below age 18 with bipolar mania due to a lack of data on efficacy
Persistent aggression in patients with moderate to severe Alzheimer's dementia : A starting dose of 0.25 mg twice daily is recommended. This dosage can be individually adjusted by increments of 0.25 mg twice daily, not more frequently than every other day, if needed. The optimum dose is 0.5 mg twice daily for most patients. Some patients, however, may benefit from doses up to 1 mg twice daily.
Risperidone tablets should not be used more than 6 weeks in patients with persistent aggression in Alzheimer's dementia. During treatment, patients must be evaluated frequently and regularly, and the need for continuing treatment reassessed.
Elderly : A starting dose of 0.5 mg twice daily is recommended. This dosage can be individually adjusted with 0.5 mg twice daily increments to 1 to 2 mg twice daily.
Conduct disorder : Children and adolescents from 5 to 18 years of age
As with all symptomatic treatments, the continued use of Risperidone tablets must be evaluated and justified on an ongoing basis.
Risperidone tablets is not recommended in children less than 5 years of age, as there is no experience in children less than 5 years of age with this disorder.
Renal and hepatic impairment : Patients with renal impairment have less ability to eliminate the active antipsychotic fraction than in adults with normal renal function. Patients with impaired hepatic function have increases in plasma concentration of the free fraction of risperidone.
Risperidone tablets should be used with caution in these groups of patients.

Additional Information:

• Packaging Details: 10 x 10 Tablets in printed carton with pack insert.